Prognostic correlation and immune characteristics of a TAM cluster- related 8-gene risk signature in triple-negative breast cancer

Author:

Miao Shichen1,Bian Chengyu2,Wang Shanshan3,You Huan1,Zhou Yi1,Fang Jun1,Ni Qichao1

Affiliation:

1. Affiliated Hospital of Nantong University

2. The First People's Hospital of Changzhou and The Third Affiliated Hospital of Soochow University

3. Nanjing Gulou Hospital Group Suqian Hospital Co., Ltd

Abstract

Abstract Tumor-associated macrophages (TAMs) play a critical role in the progression of and immune response to triple-negative breast cancer (TNBC). This study aimed to explore the features of TAMs in TNBCs, construct a risk signature associated with TAM clusters, and verify their relationship with prognosis and immune-related characteristics. Primarily, we selected four TAM clusters and determined the prognosis-related clusters in TNBC based on single-cell RNA sequencing data. Subsequently, TAM-related prognostic genes were identified by univariate Cox regression analysis and an 8-genes risk signature was constructed by LASSO regression. The analysis of immune characteristics showed a significant association between the gene signature and stromal and immune scores as well as immune cells. Multivariate analysis revealed that the risk signature was an independent prognostic factor for TNBC, and confirmed its predictive value for immunotherapeutic outcomes. The newly constructed nomogram integrating stage and TAM-based risk signatures exhibited favorable predictability and reliability for TNBC prognosis prediction. Finally, the increased expression of GPR34, one of the eight hub genes, was explored in TNBC using reverse-transcriptase polymerase chain reaction, western blot, and immunohistochemistry. Our study may allow discovering new independent prognostic factors, updating immunotherapeutic methods, and identifying effective therapeutic targets for TNBC.

Publisher

Research Square Platform LLC

Reference39 articles.

1. Nolan E, Lindeman GJ, Visvader JE (2023) Deciphering breast cancer: from biology to 1. Nolan, E., G.J. Lindeman, and J.E. Visvader, Deciphering breast cancer: from biology to the clinic. Cell, 186(8): p. 1708–1728

2. Advances in systemic therapies for triple negative breast cancer;Leon-Ferre RA;BMJ,2023

3. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer;Liedtke C;J Clin Oncol,2023

4. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial;Liu Y;Cell Res,2023

5. Dynamics and specificities of T cells in cancer immunotherapy;Oliveira G;Nat Rev Cancer,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3